Congratulations to our client Scinai Immunotherapeutics Ltd. on the completion of the acquisition of the Israeli operations of Recipharm, a leading global CDMO, and the establishment of a long-term strategic commercial collaboration between the parties.
Perry Wildes and Ephraim Friedman of our International and Hi-Tech Department worked on this transaction on behalf of Scinai Immunotherapeutics.
